We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

[NEW DELHI] Infant deaths from sepsis can be reduced almost by half with doses of healthy gut bacteria, according to the results of a randomised trial conducted in India’s Odisha state.

Results of the study, published this month (August) in Nature, show that when a ‘synbiotic’ combination of a probiotic strain of the gut bacterium Lactobacillus plantarum and a carbohydrate that promotes healthy bacteria was given to neo-natal infants for a week, the incidence of sepsis (bacterial infection of the blood) can be reduced. More importantly, the cost of the one week treatment is at a very manageable US$1 per baby.

“The primary outcome was reduction in sepsis plus death.”

Pinaki Panigrahi, University of Nebraska Medical Center

The study involved monitoring 4,556 infants — some placed randomly in a group that received the synbiotic and another group on a placebo — for over two months. Sepsis or death occurred in nine per cent of the placebo group and in just 5.4 per cent of the synbiotic group, showing a reduction of 40 per cent.

“The primary outcome,” says Pinaki Panigrahi, lead author and professor of epidemiology at the College of Public Health, University of Nebraska Medical Center, “was reduction in sepsis plus death.”

According to UNICEF, 748,000 newborns die every year in India (a quarter of the global total) with 33 per cent of them from infections.

“Neo-natal mortality has been reduced due to improvements in the health care delivery system, but deaths due to sepsis, mostly in the first week of life, have remained stagnant,” Panigrahi tells SciDev.Net. Panigrahi says synbiotic intervention can be provided universally in South Asian countries where public health resources are limited. “While some refrigeration is currently needed (to keep the good bacteria alive as a lyophilised powder), it is nothing like the cold chain required for typical injectable vaccines. The aim is to deliver it in a timely fashion (soon after birth) in an affordable manner.”

Daniel Tancredi, associate professor at the UC Davis Department of Pediatrics, California, tells SciDev.Net that the study provides “valuable evidence in favour of a particular synbiotic that is effective in preventing serious bacterial infections in young infants in one region. Further studies could establish what works in other locales.”
 This piece was produced by SciDev.Net’s Asia & Pacific desk.